On October 26, 2017 Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reported that Apricus’ third quarter 2017 financial results will be released on Thursday, November 2, 2017 at 4:01 p.m. Eastern Time (Press release, Apricus Biosciences, OCT 26, 2017, View Source [SID1234521193]). Company management will host a conference call on Thursday, November 2, 2017, at 4:30 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.

To participate by telephone, please dial (855) 780-7196 (Domestic) or (631) 485-4867 (International). The conference ID number is 8498419. The live audio webcast can be accessed via the Investor Relations’ section of Apricus’ website at www.apricusbio.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived webcast will remain available for 30 days following the live call.

On October 26, 2017 Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reported that Apricus’ third quarter 2017 financial results will be released on Thursday, November 2, 2017 at 4:01 p.m. Eastern Time (Press release, Apricus Biosciences, OCT 26, 2017, View Source [SID1234521193]). Company management will host a conference call on Thursday, November 2, 2017, at 4:30 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.

To participate by telephone, please dial (855) 780-7196 (Domestic) or (631) 485-4867 (International). The conference ID number is 8498419. The live audio webcast can be accessed via the Investor Relations’ section of Apricus’ website at www.apricusbio.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived webcast will remain available for 30 days following the live call.

Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, reported that Apricus’ third quarter 2017 financial results will be released on Thursday, November 2, 2017 at 4:01 p.m. Eastern Time (Press release, Apricus Biosciences, OCT 26, 2017, View Source [SID1234521193]). Company management will host a conference call on Thursday, November 2, 2017, at 4:30 p.m. Eastern Time to discuss the financial results and other recent corporate highlights.

To participate by telephone, please dial (855) 780-7196 (Domestic) or (631) 485-4867 (International). The conference ID number is 8498419. The live audio webcast can be accessed via the Investor Relations’ section of Apricus’ website at www.apricusbio.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived webcast will remain available for 30 days following the live call.

On October 26, 2017 Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, reported that it will announce financial results for the third quarter ended September 30, 2017 on November 2, 2017 before the NASDAQ market open (Press release, Loxo Oncology, OCT 26, 2017, https://ir.loxooncology.com/press-releases/loxo-oncology-to-announce-third-quarter-2017-financial-results-and-host-conference-call [SID1234521181]). At 8:00 a.m. ET that day, Loxo Oncology management will host a conference call to discuss these financial results, in addition to recent updates on development and corporate activities.

To participate in the conference call, please dial (877) 930-8065 (domestic) or (253) 336-8041 (international) and refer to conference ID 78661148. A replay will be available shortly after the conclusion of the call and archived on the company’s website for 30 days following the call.

On October 26, 2017 ArQule, Inc. (Nasdaq: ARQL) reported that it will report financial results for the third quarter 2017 before the market opens on Thursday, November 9, 2017 (Press release, ArQule, OCT 26, 2017, View Source [SID1234521185]). The Company will hold a conference call and webcast on the same day at 9:00 a.m. ET to discuss these results and provide a general business update.

The live webcast can be accessed in the “Investors and Media” section of our website, www.arqule.com, under “Events & Presentations.” You may also listen to the call by dialing (877) 868-1831 within the U.S. or (914) 495-8595 outside the U.S. A replay will be available two hours after the completion of the call and can be accessed in the “Investors & Media” section of our website, www.arqule.com, under “Events and Presentations.”